Nicholas Saraceno

Matts Johansen, CEO of Aker BioMarine, says the coming shortage isn't about price, but about supply disappearing entirely.

A new 5-year strategic plan and a $24 million research center aim to close the gap between organic ingredient demand and domestic farmland supply.

The deal, expected to be finalized by the end of the year, would combine botanical extraction, fermented nutrients, and natural color and flavor operations under one supplier, reshaping sourcing options for finished product manufacturers across nutraceuticals and food enhancement.

A new stateside inventory of the branded ashwagandha extract shortens lead times for manufacturers, while the underlying clinical research base continues to shape how the ingredient is positioned in stress-support formulations.

Gelita's North America marketing communications manager breaks down how rising GLP-1 usage is accelerating demand for nutrient-dense, portion-smart products, the tradeoffs between collagen and complete proteins in bar formulations, and what responsible claims substantiation looks like for collagen peptides.

Maypro's probiotic ingredient completed the FDA's New Dietary Ingredient notification process, a regulatory milestone that arrives alongside a growing body of independent human clinical research on the broader Akkermansia muciniphila category.

At IFT FIRST 2026, Foodology by Univar Solutions highlighted formulation approaches for nutrient-dense, portion-controlled products, reflecting a broader industry shift already underway as GLP-1 medication use continues to grow.

The agreement between the trade association and India's SHEFEXIL formalizes a relationship aimed at improving traceability and scientific collaboration for botanical ingredients flowing between the two countries' supplement industries.

The updated site reorganizes clinical and mechanistic data on the company's Andrographis paniculata extract, reflecting a broader industry trend toward more transparent, formulator-facing ingredient education.

The new product line reflects a broader shift in the protein beverage category toward lighter, clear-format drinks, a formulation approach that requires different processing than traditional dairy-based shakes.

As FDA continues reassessing synthetic preservatives like BHT, ingredient suppliers are positioning enzyme- and fermentate-based alternatives as replacements manufacturers can adopt ahead of anticipated regulatory shifts.

A peer-reviewed, placebo-controlled trial on a sustained-release melatonin ingredient used objective sleep monitoring rather than self-report alone, adding polysomnography-based evidence to a heavily saturated supplement category.

California Natural Color's showcase at this year's IFT event reflects a broader industry shift toward reformulating red-hued products, as synthetic dye alternatives face increasing regulatory pressure.

NPA's Daniel Fabricant, PhD, draws on his time as former director of FDA's Division of Dietary Supplement Programs to explain the agency's regulatory mindset, then lays out the association's near-term priorities.

The acquisition gives the natural ingredients group direct sourcing control at origin for a hydrocolloid increasingly used in appetite management and clean-label formulations.

In the fourth episode, Nicholas Saraceno unpacks why negative media coverage of omega-3 research doesn't always tell the full story, and what finished product manufacturers and consumers alike should understand about reading past a headline to the actual study design.

The rigid plastic packaging manufacturer's inaugural GRI-aligned report details emissions and waste reductions, offering finished product manufacturers a data point for evaluating packaging partners on sustainability performance rather than marketing claims alone.

NPA's president and CEO explains how the organization decides when to challenge industry-critical research, breaks down what he sees as “flawed” methodology in a recent glucosamine-Alzheimer's study, and weighs in on a lawsuit that could reshape how supplement health claims are made.

As spermidine research expands, an ingredient commercialized nearly 90 years ago is getting a second look from manufacturers seeking whole-food sources of the compound alongside protein and fiber.

Data on a fermentation-derived salidroside complex offers manufacturers a sustainably sourced alternative to Rhodiola rosea extract, a plant now facing supply pressure after its 2023 CITES listing.

As a new lawsuit challenges FDA's food-only interpretation of authoritative health claims, Steve Mister, president and CEO of CRN, discusses its own First Amendment case over New York's age restrictions and how Sergeant Searchlight fits into serious policy advocacy.

New ADM research spanning five countries shows pet owners are increasingly willing to pay for longevity-focused products, though what "longevity" means to them varies sharply by market.

The association’s president and CEO explains the strategy behind Sergeant Searchlight, and why voluntary product databases fall short of the mandatory registry the industry has pursued for 6 years.

The acquisition brings an established aromatherapy and essential oils brand into Country Life's portfolio, signaling continued consolidation among natural health and wellness companies.

A peer-reviewed pilot study on Exclzyme Pet reports improved mobility scores and lower inflammatory markers in arthritic dogs.

A new analysis of 5 randomized controlled trials finds a split picture: some evidence of benefit when creatine is added to standard treatment, and 3 trials that found no effect.

Nutritional Outlook interviews Andrew Ross, DO, Rousselot's science liaison and writer, who makes the case that blending collagen peptides into existing formulas isn't just a cost play, it's a functional and nutritional upgrade.

UNPA, one of the architects of the Dietary Supplement Health and Education Act, will wind down operations at the end of 2026, prompting reflection across the industry on the regulatory framework it helped build.

A randomized controlled trial reports that a low-dose saffron extract improved mood, sleep-related impairment, and self-esteem scores in women aged 50 to 70, adding a multidimensional angle to a body of research that has focused largely on depressive symptoms alone.

Vitamin K2 has become a staple cofactor in bone and cardiovascular health formulations, but the differences between its 2 major commercial forms, MK-4 and MK-7, carry real implications for dosing, claims, and sourcing.